Skip to main content
Livermore
Livermore
ZHEN

Sabby Management, LLC

SEC CIK
0001535610
Latest filing
Aug 14, 2026

The latest 13F from Sabby Management, LLC covers Q2 2026 (filed Aug 14, 2026): 16 long positions worth $12.0M. The top 10 holdings make up 94.7% of the portfolio, and the largest is SPDR S&P 500 ETF Trust (SPY) at 34.2%. Livermore has 22 filings on Form 13F from this institution, going back to Q1 2021.

What changed in Q2 2026

Share counts compared with Q1 2026: how many positions were new, added to, reduced or sold out, and the biggest buys and sells. Dollar amounts are estimated at the quarter-end prices implied by the filing.

Full comparison
New
8
Est. +$6.41M
Added
4
Est. +$2.75M
Reduced
4
Est. −$563.6K
Sold out
14
Est. −$2.55M

Top 5 holdings

Share of this quarter's portfolio value

  1. SPYSPDR S&P 500 ETF Trust
    34.2%$4.11MHistory
  2. TOYOTOYO Co., Ltd
    29.1%$3.50MHistory
  3. FAMIFarmmi, Inc.
    7.0%$840.3KHistory
  4. CRVOCervoMed Inc.
    6.4%$771.5KHistory
  5. TPSTTempest Therapeutics, Inc.
    4.7%$567.5KHistory

Biggest buys

New and added positions, by estimated amount bought

  1. TOYOTOYO Co., Ltd
    +$3.50MNewHistory
  2. SPYSPDR S&P 500 ETF Trust
    +$2.07MAddedHistory
  3. FAMIFarmmi, Inc.
    +$840.3KNewHistory
  4. CRVOCervoMed Inc.
    +$771.5KNewHistory
  5. PAVSParanovus Entertainment Technology Ltd.
    +$560.5KNewHistory

Largest weight increases

New and added positions, by percentage points of the portfolio gained

  1. TOYOTOYO Co., Ltd
    +29.13 pp0.0% → 29.1%History
  2. FAMIFarmmi, Inc.
    +6.99 pp0.0% → 7.0%History
  3. CRVOCervoMed Inc.
    +6.42 pp0.0% → 6.4%History
  4. PAVSParanovus Entertainment Technology Ltd.
    +4.66 pp0.0% → 4.7%History
  5. TPSTTempest Therapeutics, Inc.
    +4.21 pp0.5% → 4.7%History

Biggest sells

Reduced and sold-out positions, by estimated amount sold

  1. ALPAlpha Compute Corp
    −$654.8KSold outHistory
  2. DSYBig Tree Cloud Holdings Ltd
    −$337.1KSold outHistory
  3. INMInMed Pharmaceuticals Inc.
    −$271.7KReducedHistory
  4. TCToken Cat Ltd
    −$241.7KSold outHistory
  5. CPOPPop Culture Group Co., Ltd
    −$201.1KSold outHistory

Largest weight decreases

Reduced and sold-out positions, by percentage points of the portfolio lost

  1. ALPAlpha Compute Corp
    −11.46 pp11.5% → 0.0%History
  2. DSYBig Tree Cloud Holdings Ltd
    −5.90 pp5.9% → 0.0%History
  3. BCTXLBriaCell Therapeutics Corp.
    −5.46 pp6.9% → 1.4%History
  4. SNESSenesTech, Inc.
    −4.52 pp6.3% → 1.8%History
  5. TCToken Cat Ltd
    −4.23 pp4.2% → 0.0%History

Metrics

13F metrics for Q2 2026, computed only from the numbers in the filings. Definitions below.

Portfolio value
$12.0M
+$6.31M (+110.5%) vs. prior quarter
Positions
16
−6 vs. prior quarter
Top 10 concentration
94.7%
Top 10 as share of value
Turnover
35.2%
Q2 2026, one quarter
Average holding period
1.9 quarters
Weighted by value

How these are calculated

  • Portfolio value: the market value of all long positions in the 13F, as reported at quarter end, excluding options.
  • Top 10 concentration: the combined value of the 10 largest positions as a share of portfolio value.
  • Turnover: the smaller of this quarter's estimated purchases and estimated sales, divided by the average of this and last quarter's portfolio value. Estimates multiply the change in shares by the quarter-end price implied by the filing (market value divided by shares); new positions use this quarter's value and sold-out positions last quarter's. Only positions reported in shares count, and it is not calculated when the previous quarter was not filed.
  • Average holding period: how many consecutive quarters each current position has been held (including this one; a quarter without the position or without a filing starts the count over), weighted by this quarter's value. Counting starts with the first 13F in Livermore (Q1 2021), so positions held before then are understated.

13F filings by quarter

22 quarters, going back to Q1 2021. Bars show each quarter's 13F portfolio value; quarters without a filing are left blank.

Peak $462.3M (Q2 2021)

Q1 2021: $135.9MQ2 2021: $462.3MQ3 2021: $456.2MQ4 2021: $400.7MQ1 2022: $233.2MQ2 2022: $54.0MQ3 2022: $46.2MQ4 2022: $37.3MQ1 2023: $26.9MQ2 2023: $27.9MQ3 2023: $31.6MQ4 2023: $11.3MQ1 2024: $15.3MQ2 2024: $7.53MQ3 2024: $7.22MQ4 2024: $12.3MQ1 2025: $23.8MQ2 2025: $13.0MQ3 2025: $19.3MQ4 2025: $12.0MQ1 2026: $5.71MQ2 2026: $12.0M
Q1 2021Q2 2026
13F filings of Sabby Management, LLC by quarter
QuarterFiledPositionsValueTop 3 holdingsChangesFiling
Q2 2026Aug 14, 202616$12.0MSPYTOYOFAMIvs. Q1 2026SEC
Q1 2026May 15, 202622$5.71MSPYALPBCTXLvs. Q4 2025SEC
Q4 2025Feb 17, 202625$12.0MDSYEMPDBLNKvs. Q3 2025SEC
Q3 2025Nov 14, 202529$19.3MDSYEMPDCPOPvs. Q2 2025SEC
Q2 2025Aug 14, 202533$13.0MTPSTEOSELYRAvs. Q1 2025SEC
Q1 2025May 15, 202536$23.8MSRFMiShares Russell 2000 ETFLLYvs. Q4 2024SEC
Q4 2024Feb 14, 202516$12.3MEOSESPYiShares Russell 2000 ETFvs. Q3 2024SEC
Q3 2024Nov 14, 202427$7.22MVANIEMPDHCWCvs. Q2 2024SEC
Q2 2024Aug 14, 202427$7.53MVANICORZWRDHLvs. Q1 2024SEC
Q1 2024May 15, 202444$15.3MVANIELTKCore Scientific, Inc.vs. Q4 2023SEC
Q4 2023Feb 14, 202446$11.3MTNXPBynd Cannasoft Enterprises IMMATvs. Q3 2023SEC
Q3 2023Nov 14, 202366$31.6MiShares Russell 2000 ETFSPYSEELvs. Q2 2023SEC
Q2 2023Aug 14, 202368$27.9MBrainstorm Cell TherapeuticsBIORSonnet Biotherapeutc HLDNG Ivs. Q1 2023SEC
Q1 2023May 15, 202372$26.9MNMTRAKTXTCvs. Q4 2022SEC
Q4 2022Feb 14, 202389$37.3MNVCTTBLTDOGZvs. Q3 2022SEC
Q3 2022Nov 14, 202283$46.2MBGXXNVCTDOGZvs. Q2 2022SEC
Q2 2022Aug 15, 202276$54.0MGEVODOGZMMATvs. Q1 2022SEC
Q1 2022May 16, 202285$233.2MIon Geophysical CorpCOCPPMCBvs. Q4 2021SEC
Q4 2021Feb 14, 2022105$400.7MIon Geophysical CorpBTBTBit Mining Limitedvs. Q3 2021SEC
Q3 2021Nov 15, 202194$456.2MIon Geophysical CorpBTBTBit Minin-SP ADRvs. Q2 2021SEC
Q2 2021Aug 16, 202185$462.3MIon Geophysical CorpSRNECOCPvs. Q1 2021SEC
Q1 2021May 17, 202182$135.9MSRNEVANIASXC–SEC

13D and 13G filings

Companies where Sabby Management, LLC reports owning 5% or more on Schedule 13D or 13G, and its latest filings.

Current stakes of 5% or more

13 companies, largest stake first.

Companies where Sabby Management, LLC owns 5% or more
CompanyLatest formStakeChangeFirst filedLatest filingFiling
FOXOFoxo Technologies Inc.13G9.90%249.3M sharesNewJan 21, 20261 filingJan 21, 2026SEC
CYNCyngn Inc.13G/A9.90%2.15M shares–Jan 4, 20242 filingsJan 3, 2025SEC
TPSTTempest Therapeutics, Inc.13G9.90%492.2K sharesNewJan 21, 20261 filingJan 21, 2026SEC
OGENOragenics Inc13G9.90%412.7K sharesNewJan 21, 20261 filingJan 21, 2026SEC
INMInMed Pharmaceuticals Inc.13G9.90%280.1K sharesNewJan 20, 20261 filingJan 20, 2026SEC
BDRXBiodexa Pharmaceuticals Plc13G9.90%217.6K sharesNewJan 20, 20261 filingJan 20, 2026SEC
GVHGlobavend Holdings Ltd13G9.90%211.5K sharesNewJan 21, 20261 filingJan 21, 2026SEC
JZXNJiuzi Holdings, Inc.13G/A9.90%206.3K shares0.00 ppfrom 9.90%Jan 20, 20262 filingsJan 21, 2026SEC
LYRALyra Therapeutics, Inc.13G9.90%175.2K sharesNewJan 20, 20261 filingJan 20, 2026SEC
REVBRevelation Biosciences, Inc.13G9.60%605.7K sharesNewJan 20, 20261 filingJan 20, 2026SEC
DSYBig Tree Cloud Holdings Ltd13G6.60%5.77M sharesNewJan 20, 20261 filingJan 20, 2026SEC
NUWENuwellis, Inc.13G5.40%89.7K sharesNewJan 20, 20261 filingJan 20, 2026SEC
TCToken Cat Ltd13G/A5.00%146.8K shares–Jan 4, 20232 filingsJan 2, 2025SEC

Latest filings

240 filings on file made by Sabby Management, LLC or listing it as a reporting person; the latest 20 are shown.

Schedule 13D and 13G filings by Sabby Management, LLC
CompanyFiled (ET)FormStakeChangeEvent dateFiling
OGENOragenics IncJan 21, 202610:14 AM ET13G9.90%412.7K sharesNewDec 31, 2025SEC
TPSTTempest Therapeutics, Inc.Jan 21, 20269:27 AM ET13G9.90%492.2K sharesNewDec 31, 2025SEC
JZXNJiuzi Holdings, Inc.Jan 21, 20268:58 AM ET13G/A9.90%206.3K shares0.00 ppfrom 9.90%Dec 31, 2025SEC
GVHGlobavend Holdings LtdJan 21, 20268:44 AM ET13G9.90%211.5K sharesNewDec 31, 2025SEC
FOXOFoxo Technologies Inc.Jan 21, 20267:54 AM ET13G9.90%249.3M sharesNewDec 31, 2025SEC
REVBRevelation Biosciences, Inc.Jan 20, 20268:31 PM ET13G9.60%605.7K sharesNewDec 31, 2025SEC
NUWENuwellis, Inc.Jan 20, 20267:54 PM ET13G5.40%89.7K sharesNewDec 31, 2025SEC
LYRALyra Therapeutics, Inc.Jan 20, 20267:18 PM ET13G9.90%175.2K sharesNewDec 31, 2025SEC
JZXNJiuzi Holdings, Inc.Jan 20, 20263:14 PM ET13G9.90%206.3K sharesNewDec 31, 2025SEC
INMInMed Pharmaceuticals Inc.Jan 20, 20262:25 PM ET13G9.90%280.1K sharesNewDec 31, 2025SEC
BDRXBiodexa Pharmaceuticals PlcJan 20, 20261:49 PM ET13G9.90%217.6K sharesNewDec 31, 2025SEC
DSYBig Tree Cloud Holdings LtdJan 20, 202612:48 PM ET13G6.60%5.77M sharesNewDec 31, 2025SEC
UPCUniverse Pharmaceuticals INCJan 7, 20263:37 PM ET13G/A4.90%28.1K shares−5.00 ppfrom 9.90%Below 5%Dec 31, 2025SEC
EMPDEmpery Digital Inc.Jan 7, 20263:05 PM ET13G/A1.30%479.4K shares−8.60 ppfrom 9.90%Below 5%Dec 31, 2025SEC
BNBXBNB Plus Corp.Jan 7, 20262:19 PM ET13G/A4.90%217.8K shares−5.10 ppfrom 10.00%Below 5%Dec 31, 2025SEC
RNAZTranscode Therapeutics, Inc.Jan 7, 202612:38 PM ET13G/A4.90%41.6K shares−5.00 ppfrom 9.90%Below 5%Dec 31, 2025SEC
CYNCyngn Inc.Jan 7, 202612:03 PM ET13G/A1.00%77.7K shares–Below 5%Dec 31, 2025SEC
UPCUniverse Pharmaceuticals INCJan 3, 20258:51 PM ET13G9.90%727.2K sharesNewDec 31, 2024SEC
EMPDEmpery Digital Inc.Jan 3, 20258:18 PM ET13G9.90%56.0K sharesNewDec 31, 2024SEC
BNBXBNB Plus Corp.Jan 3, 20257:50 PM ET13G10.00%5.22M sharesNewDec 31, 2024SEC